AHR-16462B

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameAHR-16462B

Drug Alias NameAHR-16462B

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated calcium channel blockers

TargetsVoltage-gated calcium channel

Therapy Area/IndicationsHypertensionCoronary Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsHypertensionCoronary Disease

ATC CodeN/A